Sophie Scheidlinger
Latest from Sophie Scheidlinger
-
Sophie Scheidlinger · September 12, 2016
CMS expands reporting options for the Quality Payment Program starting in 2017
Andy Slavitt, the Acting Administrator of the Centers for Medicare and Medicaid Services (CMS), recently published a detailed blog postoutlining the reporting options available to providers participating in the Quality Payment Program (QPP)](/value-based-reimbursement/), which is scheduled to start in 2017.
Continue
-
Sophie Scheidlinger · August 29, 2016
Is the Comprehensive Primary Care Plus (CPC+) care model right for your practice?
The Center for Medicare & Medicaid Innovation recently released information about a new care model called Comprehensive Primary Care Plus (CPC+), which succeeds the Comprehensive Primary Care initiative running from October 2012 through the end of 2016.
Continue
-
Sophie Scheidlinger · January 22, 2016
CMS Administrator Andy Slavitt, MACRA, and Meaningful Use 3: The Practice Fusion perspective
If you haven’t heard by now, CMS Acting Administrator Andy Slavitt’s presentation at the J.P. Morgan Annual Health Care Conference set the industry abuzz. Perhaps due to all the speculation this speech created, he then released a blog post with Acting Assistant Secretary for Health...
Continue
-
Sophie Scheidlinger · January 5, 2016
Meaningful Use Stage 2 measures are now Stage 2 objectives
CMS has amended Meaningful Use Stage 2 for the 2015 reporting period and beyond. Practices that are reporting for Stage 2 in 2015 will now report on the reduced Stage 2 objectives based on the new CMS requirements.
Continue
-
Sophie Scheidlinger · December 22, 2015
Meaningful Use: 6 things you need to know about the CMS Final Rule changes
After ongoing feedback from medical providers, professional medical associations, and Congress, the Centers for Medicare and Medicaid Services (CMS) released changes to the Meaningful Use program on October 16, 2015. These changes take effect starting 2015 and continue through 2017. The intended aim of this...
Continue